SCHEMBL14547744

SCHEMBL14547744

COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)COC(=O)[C@@H](N)C(C)C)C[C@@H]3OC1CC(N)C(O)C(C)O1

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 10/20 0.80
THRB P10828 10/20 0.80
KMT2A Q03164 10/20 0.80
BLM P54132 9/20 0.80
RECQL P46063 8/20 0.80
SMN1; SMN2 Q16637 7/20 0.80
MAPT P10636 7/20 0.80
HIF1A Q16665 6/20 0.80
BRCA1 P38398 6/20 0.80
TDP1 Q9NUW8 6/20 0.80
TOP2A P11388 5/20 0.80
MAPK1 P28482 5/20 0.80
HTT P42858 5/20 0.80
CHRM1 P11229 4/20 0.80
STAT6 P42226 4/20 0.80
KDM4E B2RXH2 4/20 0.80
ALDH1A1 P00352 4/20 0.80
TBXA2R P21731 3/20 0.80
ABCB1 P08183 3/20 0.80
NR3C1 P04150 3/20 0.80

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14547833 1.00 MEN1 (0.80) MEN1THRBKMT2ABLMRECQL
Detorubicin SCHEMBL8642 0.92 MEN1 (0.81) MEN1THRBKMT2ABLMRECQL
Detorubicin SCHEMBL27821471 0.92 MEN1 (0.81) MEN1THRBKMT2ABLMRECQL
Detorubicin SCHEMBL29771309 0.92 MEN1 (0.81) MEN1THRBKMT2ABLMRECQL
SCHEMBL14524971 0.91 MEN1 (0.84) MEN1THRBKMT2ABLMRECQL
SCHEMBL14867452 0.91 MEN1 (0.84) MEN1THRBKMT2ABLMRECQL
SCHEMBL17899481 0.91 MEN1 (0.88) MEN1THRBKMT2ABLMRECQL
SCHEMBL13742595 0.91 MEN1 (0.88) MEN1THRBKMT2ABLMRECQL
SCHEMBL20801118 0.91 MEN1 (0.88) MEN1THRBKMT2ABLMRECQL
SCHEMBL22513656 0.91 MEN1 (0.88) MEN1THRBKMT2ABLMRECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070093645-A1 Peptide vectors SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATION (FR) 2007-04-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070093645-A1 Peptide vectors TP53, VIP, XIAP MEN1 404/4885THRB 2283/4885KMT2A 3870/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.